Jazz Pharma director may sell 3,507 shares

Jazz Pharmaceuticals plc (JAZZ) received a notice under Rule 144 that director Laura Hamill may sell shares of the company’s common stock.

Rhea-AI Filing Summary

Jazz Pharmaceuticals plc (JAZZ) received a notice under Rule 144 that director Laura Hamill may sell shares of the company’s common stock. The planned sale covers 3,507 common shares, which were acquired from the issuer through restricted stock vesting as compensation. E*TRADE Financial Corporation is listed as the broker.

Key Figures

Common shares to be sold: 3,507 shares Security type: Common stock Acquisition method: Restricted stock vesting +1 more

4 metrics

Common shares to be sold 3,507 shares Potential sale under Rule 144 for account of director Laura Hamill

Security type Common stock Class of securities covered by the Rule 144 notice

Acquisition method Restricted stock vesting Method by which the 3,507 shares were acquired from the issuer

Relationship to issuer Director Status of Laura Hamill at Jazz Pharmaceuticals plc

Key Terms

Rule 144, restricted stock vesting, compensation, power of attorney

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"COMMON | 08/28/2026 | RESTRICTED STOCK VESTING | ISSUER"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

compensation financial

"3507 | 08/28/2026 | Compensation"

power of attorney regulatory

"Signature | /s/Paz Dizon by power of attorney for Laura Hamill"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for JAZZ disclose about Laura Hamill?

The filing states that director Laura Hamill may sell 3,507 shares of Jazz Pharmaceuticals plc common stock under Rule 144. These shares were acquired from the issuer through restricted stock vesting as compensation, with E*TRADE Financial Corporation listed as the broker.

How many JAZZ shares are covered by this Form 144 notice?

The notice covers a potential sale of 3,507 shares of Jazz Pharmaceuticals plc common stock. These shares are reported as having been acquired through restricted stock vesting from the issuer as part of compensation.

What type of JAZZ securities are involved in Laura Hamill’s Form 144?

The securities are common shares of Jazz Pharmaceuticals plc. The Form 144 identifies them as shares acquired via restricted stock vesting from the issuer as compensation, with a planned sale of 3,507 shares under Rule 144.

How were the JAZZ shares in this Form 144 acquired?

The Form 144 states that the 3,507 common shares were acquired through restricted stock vesting from Jazz Pharmaceuticals plc as compensation to director Laura Hamill.

Which broker is listed for the potential sale of JAZZ shares?

The broker listed is E*TRADE Financial Corporation, associated with the 3,507 common shares of Jazz Pharmaceuticals plc that may be sold under Rule 144 for the account of director Laura Hamill.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 03:42 PM EDT Accepted by SEC EDGAR 08/31/2026 - 03:41 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001751804
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Jazz Pharmaceuticals plc
SEC File Number	001-33500
Address of Issuer	FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN IRELAND D04 E5W7
Phone	353-1-634-7800
Name of Person for Whose Account the Securities are To Be Sold	Hamill Laura
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	ETRADE FINANCIAL CORPORATION 3 EDISON DRIVE ALPHARETTA GA 30005	3507	857602.00	64914577	08/31/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	08/28/2026	RESTRICTED STOCK VESTING	ISSUER			3507	08/28/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Paz Dizon by power of attorney for Laura Hamill
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)